4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0000947871-26-000461
Director bought 2,815,315 shares at $4.44 ($12,499,999)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC Director | 2026-04-21 | Purchase | +1,689,189 | $4.44 | $7,499,999 | 11,808,945 | I |
| ORBIMED ADVISORS LLC Director | 2026-04-21 | Purchase | +1,126,126 | $4.44 | $4,999,999 | 1,126,126 | I |
| Open-market purchases · 2,815,315 sh · avg $4.44 · $12,499,999 | |||||||
Loading xslF345X06/ownership.xml…